<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35898449</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms.</ArticleTitle><Pagination><StartPage>896378</StartPage><MedlinePgn>896378</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">896378</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2022.896378</ELocationID><Abstract><AbstractText Label="AIMS">Pre-existing conditions, such as age, hypertension, obesity, and diabetes, constitute known risk factors for severe COVID-19. However, the impact of prediabetes mellitus (PDM) on COVID-19 severity is less clear. This study aimed to evaluate the influence of PDM in the acute and long-term phases of COVID-19.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We compared inflammatory mediators, laboratory and clinical parameters and symptoms in COVID-19 patients with prediabetes (PDM) and without diabetes (NDM) during the acute phase of infection and at three months post-hospitalization.</AbstractText><AbstractText Label="RESULTS">Patients with PDM had longer hospital stays and required intensive care unit admission more frequently than NDM. Upon hospitalization, PDM patients exhibited higher serum levels of interleukin 6 (IL-6), which is related to reduced partial pressure of oxygen (PaO<sub>2</sub>) in arterial blood, oxygen saturation (SpO<sub>2</sub>) and increased COVID-19 severity. However, at three months after discharge, those with PDM did not exhibit significant alterations in laboratory parameters or residual symptoms; however, PDM was observed to influence the profile of reported symptoms.</AbstractText><AbstractText Label="CONCLUSIONS">PDM seems to be associated with increased risk of severe COVID-19, as well as higher serum levels of IL-6, which may constitute a potential biomarker of severe COVID-19 risk in affected patients. Furthermore, while PDM correlated with more severe acute-phase COVID-19, no long-term worsening of sequelae was observed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Bonyek-Silva, Cerqueira-Silva, Nunes, Machado, Cruz, Pereira, Estrela, Silva, Isis, Barral, Oliveira, Khouri, Serezani, Brodskyn, Caldas, Barral-Netto, Boaventura and Tavares.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonyek-Silva</LastName><ForeName>Icaro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal Institute of Education, Science and Technology Baiano, Xique-Xique, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Santa Cruz of Bahia (FSC), Nursing School, Itaberaba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerqueira-Silva</LastName><ForeName>Thiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Ant&#xf4;nio Fernando Ara&#xfa;jo</ForeName><Initials>AFA</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Salvador University (UNIFACS), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>M&#xe1;rcio Rivison Silva</ForeName><Initials>MRS</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Salvador University (UNIFACS), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Blenda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estrela</LastName><ForeName>Leilane</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>J&#xe9;ssica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isis</LastName><ForeName>Ananda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barral</LastName><ForeName>Aldina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology (INCT), Institute of Investigation in Immunology (iii-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Pablo Rafael Silveira</ForeName><Initials>PRS</Initials><AffiliationInfo><Affiliation>Institute of Biological Sciences, Federal University of Bahia (IBio-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khouri</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serezani</LastName><ForeName>C Henrique</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodskyn</LastName><ForeName>Cl&#xe1;udia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology (INCT), Institute of Investigation in Immunology (iii-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldas</LastName><ForeName>Juliana Ribeiro</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>School of Health Sciences, Salvador University (UNIFACS), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Unit, S&#xe3;o Rafael Hospital - Rede d'Or, Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bahiana School of Medicine and Public Health - EBMSP, Campus Brotas, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barral-Netto</LastName><ForeName>Manoel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology (INCT), Institute of Investigation in Immunology (iii-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boaventura</LastName><ForeName>Viviane</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavares</LastName><ForeName>Natalia Machado</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Gon&#xe7;alo Moniz Institute (IGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Federal University of Bahia (FAMEB-UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology (INCT), Institute of Investigation in Immunology (iii-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK122147</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL124159</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI149207</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011236" MajorTopicYN="Y">Prediabetic State</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IL-6</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">prediabetes</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>2</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35898449</ArticleId><ArticleId IdType="pmc">PMC9311489</ArticleId><ArticleId IdType="doi">10.3389/fendo.2022.896378</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LFP. The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nat Rev Immunol (2020) 20:363&#x2013;74. doi:&#xa0;10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA - J Am Med Assoc (2020) 323:2052&#x2013;9. doi:&#xa0;10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonyek-Silva I, Machado AFA, Cerqueira-Silva T, Nunes S, Cruz MRS, Silva J, et al. . LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes. Diabetes (2021) 70:2120&#x2013;2030. doi:&#xa0;10.2337/db20-1260</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db20-1260</ArticleId><ArticleId IdType="pmc">PMC8576416</ArticleId><ArticleId IdType="pubmed">34417262</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC, Davanzo GG, Monteiro LDB, Souza GF De, Muraro SP, Carregari VC, et al. . Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response Through a HIF-1&#x3b1;/Glycolysis Dependent Axis. Cell Metab (2020) 32:498&#x2013;499. doi: 10.2139/ssrn.3606770</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3606770</ArticleId><ArticleId IdType="pmc">PMC7462530</ArticleId><ArticleId IdType="pubmed">32877692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijnant SR, Jacobs M, Van Eeckhoutte HP, Lapauw B, Joos GF, Bracke KR, et al. . Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes. Diabetes (2020) 69(12):2691&#x2013;2699. doi:&#xa0;10.2337/db20-0669</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db20-0669</ArticleId><ArticleId IdType="pubmed">33024003</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A, Gambardella J, Sardu C, Santulli G. MiR-98 Regulates Tmprss2 Expression in Human Endothelial Cells: Key Implications for Covid-19. Biomedicines (2020) 8:1&#x2013;10. doi:&#xa0;10.3390/biomedicines8110462</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8110462</ArticleId><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Onofrio N, Scisciola L, Sardu C, Trotta MC, De Feo M, Maiello C, et al. . Glycated ACE2 Receptor in Diabetes: Open Door for SARS-COV-2 Entry in Cardiomyocyte. Cardiovasc Diabetol (2021) 20:1&#x2013;16. doi:&#xa0;10.1186/s12933-021-01286-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01286-7</ArticleId><ArticleId IdType="pmc">PMC8104461</ArticleId><ArticleId IdType="pubmed">33962629</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Tian S, Chen T, Cui Z, Shi N, Zhong X, et al. . Newly Diagnosed Diabetes is Associated With a Higher Risk of Mortality Than Known Diabetes in Hospitalized Patients With COVID-19. Diabetes Obes Metab (2020) 22:1897&#x2013;906. doi:&#xa0;10.1111/dom.14099</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14099</ArticleId><ArticleId IdType="pmc">PMC7283710</ArticleId><ArticleId IdType="pubmed">32469464</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Chandrasekaran ND. Is Prediabetes a Risk Factor for Severe COVID-19? J Diabetes (2021) 13:521&#x2013;2. doi:&#xa0;10.1111/1753-0407.13165</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13165</ArticleId><ArticleId IdType="pmc">PMC8014723</ArticleId><ArticleId IdType="pubmed">33559395</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-V&#xe1;zquez A, Bello-Chavolla OY, Ortiz-Brizuela E, Campos-Mu&#xf1;oz A, Mehta R, Villanueva-Reza M, et al. . Impact of Undiagnosed Type 2 Diabetes and Pre-Diabetes on Severity and Mortality for SARS-CoV-2 Infection. BMJ Open Diabetes Res Care (2021) 9:1&#x2013;7. doi:&#xa0;10.1136/bmjdrc-2020-002026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2020-002026</ArticleId><ArticleId IdType="pmc">PMC7887863</ArticleId><ArticleId IdType="pubmed">33593750</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Boppana A, Traupman JA, Unson E, Maddock DA, Chao K, et al. . Impaired Glucose Metabolism in Patients With Diabetes, Prediabetes, and Obesity is Associated With Severe COVID-19. J Med Virol (2021) 93:409&#x2013;15. doi:&#xa0;10.1002/jmv.26227</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26227</ArticleId><ArticleId IdType="pmc">PMC7361926</ArticleId><ArticleId IdType="pubmed">32589756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sourij H, Aziz F, Br&#xe4;uer A, Ciardi C, Clodi M, Fasching P, et al. . COVID-19 Fatality Prediction in People With Diabetes and Prediabetes Using a Simple Score Upon Hospital Admission. Diabetes Obes Metab (2021) 23:589&#x2013;98. doi:&#xa0;10.1111/dom.14256</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14256</ArticleId><ArticleId IdType="pmc">PMC7753560</ArticleId><ArticleId IdType="pubmed">33200501</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatti R, Khamis AH, Khatib S, Shiraz S, Matfin G. Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study. JMIR Public Heal Surveill (2020) 6:1&#x2013;10. doi:&#xa0;10.2196/22471</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/22471</ArticleId><ArticleId IdType="pmc">PMC7722483</ArticleId><ArticleId IdType="pubmed">33284130</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh H, Moh AMC, Yeoh E, Lin Y, Low SKM, Ooi ST, et al. . Diabetes Predicts Severity of COVID-19 Infection in a Retrospective Cohort: A Mediatory Role of the Inflammatory Biomarker C-Reactive Protein. J Med Virol (2021) 93:3023&#x2013;32. doi:&#xa0;10.1002/jmv.26837</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26837</ArticleId><ArticleId IdType="pmc">PMC8013709</ArticleId><ArticleId IdType="pubmed">33527464</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee LY, Alhamid SM, Tan JL, Oo T, Chien J, Galinato P, et al. . COVID-19 and Undiagnosed Pre-Diabetes or Diabetes Mellitus Among International Migrant Workers in Singapore. Front Public Heal (2020) 8:584249. doi:&#xa0;10.3389/fpubh.2020.584249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.584249</ArticleId><ArticleId IdType="pmc">PMC7686043</ArticleId><ArticleId IdType="pubmed">33262970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao P, Song Y, Zhuang Z, Ran J, Xu L, Geng Y, et al. . Obesity and COVID-19 in Adult Patients With Diabetes. Diabetes (2021) 70(5):1061&#x2013;1069. doi: 10.2337/figshare.13952738</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/figshare.13952738</ArticleId><ArticleId IdType="pubmed">33597204</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. . Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care (2020) 43:1382&#x2013;91. doi:&#xa0;10.2337/dc20-0598</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0598</ArticleId><ArticleId IdType="pubmed">32409504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet (2020) 395:1054&#x2013;62. doi:&#xa0;10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, D&#x2019;Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. . Hyperglycaemia on Admission to Hospital and COVID-19. Diabetologia (2020) 63:2486&#x2013;7. doi:&#xa0;10.1007/s00125-020-05216-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05216-2</ArticleId><ArticleId IdType="pmc">PMC7335920</ArticleId><ArticleId IdType="pubmed">32632527</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R, Paolisso P, Sardu C, Bergamaschi L, D&#x2019;Angelo EC, Barbieri M, et al. . Negative Impact of Hyperglycaemia on Tocilizumab Therapy in Covid-19 Patients. Diabetes Metab (2020) 46:403&#x2013;5. doi:&#xa0;10.1016/j.diabet.2020.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.05.005</ArticleId><ArticleId IdType="pmc">PMC7241396</ArticleId><ArticleId IdType="pubmed">32447102</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. . Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 are Disease Severity Predictors. Emerg Microbes Infect (2020) 9:1123&#x2013;30. doi:&#xa0;10.1080/22221751.2020.1770129</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, D&#x2019;Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. . Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care (2020) 43:1408&#x2013;15. doi:&#xa0;10.2337/dc20-0723</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0723</ArticleId><ArticleId IdType="pmc">PMC7305003</ArticleId><ArticleId IdType="pubmed">32430456</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. . Risk Factors for Severity and Mortality in Adult COVID-19 Inpatients in Wuhan. J Allergy Clin Immunol (2020) 146:110&#x2013;8. doi:&#xa0;10.1016/j.jaci.2020.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.006</ArticleId><ArticleId IdType="pmc">PMC7152876</ArticleId><ArticleId IdType="pubmed">32294485</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. . Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. J Clin Invest (2020) 130:2620&#x2013;9. doi:&#xa0;10.1172/JCI137244</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, de Sa&#xed; KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. . Inflammasome Activation in COVID-19 Patients. Heal Eval Promot (2020) 47:248&#x2013;50. doi:&#xa0;10.7143/jhep.47.248</Citation><ArticleIdList><ArticleId IdType="doi">10.7143/jhep.47.248</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-Month Consequences of COVID-19 in Patients Discharged From Hospital: A Cohort Study. Lancet (2021) 397:220&#x2013;32. doi:&#xa0;10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci Rep (2021) 11:1&#x2013;12. doi:&#xa0;10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Susana P-C, Hern&#xe1;ndez-Barrera V, et al. . Diabetes and the Risk of Long-Term Post-COVID Symptoms. Diabetes (2021) 70(12):2917&#x2013;2921. doi:&#xa0;10.2337/db21-0329</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0329</ArticleId><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. . Multiorgan Impairment in Low-Risk Individuals With Post-COVID-19 Syndrome: A Prospective, Community-Based Study. BMJ Open (2021) 11:2&#x2013;7. doi:&#xa0;10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune Determinants of COVID-19 Disease Presentation and Severity. Nat Med (2021) 27:28&#x2013;33. doi:&#xa0;10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case Report and Systematic Review Suggest That Children may Experience Similar Long-Term Effects to Adults After Clinical COVID-19. Acta Paediatr Int J Paediatr (2021) 110:914&#x2013;21. doi:&#xa0;10.1111/apa.15673</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>